MarketCap
Facebook
X
Telegram
Accolade Net Income | ACCD
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Accolade
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -99.8 M | -460 M | -123 M | -50.7 M | -51.4 M | -56.5 M | -61.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -50.7 M | -460 M | -129 M |
Quarterly Net Income Accolade
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -121 M | -23.9 M | -27.6 M | -121 M | -23.9 M | -27.6 M | - | -21.1 M | -32.8 M | -38.4 M | - | -39.9 M | -46.5 M | -343 M | - | 22.5 M | -88.6 M | -48.7 M | -48.7 M | -16.6 M | -16.6 M | -15.4 M | -14 M | -18.3 M | -15 M | -15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.5 M | -343 M | -49.7 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Health information services industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Teladoc Health
TDOC
|
-200 M | $ 6.26 | 0.24 % | $ 1.1 B |  USA |
 |
10x Genomics
TXG
|
-43.5 M | $ 65.6 | 4.71 % | $ 8.18 B | USA |
 |
Veeva Systems
VEEV
|
909 M | $ 264.84 | 1.3 % | $ 43.3 B | USA |
 |
Zhongchao
ZCMD
|
-6.31 M | $ 0.85 | 0.29 % | $ 2.91 M |  China |
 |
Cerner Corporation
CERN
|
556 M | - | - | $ 27.9 B | USA |
 |
Change Healthcare
CHNG
|
-57.4 M | - | - | $ 9.03 B | USA |
 |
Covetrus
CVET
|
-54 M | - | - | $ 2.94 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
-292 M | - | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
-67.8 M | - | -46.64 % | $ 10.4 M | USA |
 |
1Life Healthcare
ONEM
|
-398 M | - | - | $ 3.37 B | USA |
 |
R1 RCM
RCM
|
97.2 M | - | - | $ 3.81 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-148 M | - | - | $ 255 M | USA |
 |
Signify Health
SGFY
|
-577 M | - | -0.02 % | $ 7.21 B | USA |
 |
American Well Corporation
AMWL
|
-95.7 M | $ 13.34 | 2.69 % | $ 214 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-62.2 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
70.1 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
22.6 M | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
-579 M | $ 4.22 | 1.41 % | $ 482 M | USA |
 |
GoodRx Holdings
GDRX
|
30.4 M | $ 3.52 | 1.15 % | $ 1.25 B | USA |
 |
Health Catalyst
HCAT
|
-178 M | $ 1.7 | 0.59 % | $ 119 M | USA |
 |
HealthEquity
HQY
|
215 M | $ 93.36 | 0.24 % | $ 8.04 B | USA |
 |
HealthStream
HSTM
|
18.3 M | $ 28.72 | 1.78 % | $ 862 M | USA |
 |
So-Young International
SY
|
-242 M | $ 2.65 | 0.18 % | $ 206 M | China |
 |
iCAD
ICAD
|
-5.62 M | - | - | $ 102 M | USA |
 |
Omnicell
OMCL
|
2.05 M | $ 33.88 | 0.32 % | $ 1.56 B | USA |
 |
OptimizeRx Corporation
OPRX
|
5.13 M | $ 7.6 | 1.74 % | $ 141 M | USA |
 |
Progyny
PGNY
|
58.5 M | $ 27.15 | 4.66 % | $ 2.31 B | USA |
 |
Phreesia
PHR
|
2.31 M | $ 10.22 | 0.76 % | $ 611 M | USA |
 |
NextGen Healthcare
NXGN
|
-2.65 M | - | - | $ 1.6 B | USA |
 |
Computer Programs and Systems
CPSI
|
4.35 M | - | 4.4 % | $ 133 M | USA |
 |
Akerna Corp.
KERN
|
-153 M | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
10.8 K | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
17.9 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
-103 M | $ 20.03 | 0.2 % | $ 1.47 B | USA |
 |
Streamline Health Solutions
STRM
|
-10.2 M | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
-4.44 M | - | - | $ 7.71 M | USA |